Stay updated with breaking news from Nasdaq Podd. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Insulet Co. (NASDAQ:PODD – Get Free Report) has been given a consensus rating of “Moderate Buy” by the eighteen research firms that are covering the company, Marketbeat reports. Six analysts have rated the stock with a hold recommendation and twelve have given a buy recommendation to the company. The average twelve-month price target among brokers […]
Fjarde AP Fonden Fourth Swedish National Pension Fund boosted its stake in Insulet Co. (NASDAQ:PODD – Free Report) by 6.5% during the 2nd quarter, according to the company in its most recent disclosure with the SEC. The firm owned 9,900 shares of the medical instruments supplier’s stock after acquiring an additional 600 shares during the […]
Oppenheimer Asset Management Inc. decreased its holdings in shares of Insulet Co. (NASDAQ:PODD – Free Report) by 1.5% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 22,229 shares of the medical instruments supplier’s stock after selling 342 shares during the quarter. […]
Shares of Insulet Co. (NASDAQ:PODD – Get Free Report) traded down 3.1% on Tuesday . The company traded as low as $142.21 and last traded at $142.38. 313,121 shares were traded during mid-day trading, a decline of 65% from the average session volume of 884,370 shares. The stock had previously closed at $147.00. Wall Street […]
SVB Leerink assumed coverage on shares of Insulet (NASDAQ:PODD – Free Report) in a report released on Monday, Benzinga reports. The firm issued an outperform rating and a $184.00 price objective on the medical instruments supplier’s stock. PODD has been the topic of several other research reports. Raymond James cut their target price on Insulet […]